Zdrowie i gospodarka · 11/07/2014

FDA Releases Draft Guidance for Industry on Reporting Drug Sample Information Under Affordable Care Act

The Food and Drug Administration (FDA) has released a draft guidance for industry on reporting drug sample information under Section 6004 of the Affordable Care Act (ACA), which was signed into law on March 23, 2010.